Palisade Bio PALI
NASDAQ PALI
$1.13 -0.07 (-5.46%)
As of: Nov 10, 2026 · 3:19 PM EST

Palisade Bio (PALI) Restructuring Costs (2022 - 2023)

Updated

Palisade Bio's Restructuring Costs was $225,000 in Q4 2023.

Analysis

Palisade Bio (PALI) Restructuring Costs (2022 - 2023) Analysis & Trends

  • In earlier years, Restructuring Costs was $410,000 in FY2022.
  • The Q4 2023 figure marks the highest quarterly Restructuring Costs since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Palisade Bio 249.43 Mn -147.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 225,000.00
Sep 30, 2022 410,000.00
API Access

Palisade Bio Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PALI&period=max&api_key=YOUR_API_KEY